GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Universal Biotech Co Ltd (SZSE:301166) » Definitions » Research & Development

Shanghai Universal Biotech Co (SZSE:301166) Research & Development : ¥63 Mil (TTM As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai Universal Biotech Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Shanghai Universal Biotech Co's Research & Development for the three months ended in Mar. 2025 was ¥15 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ¥63 Mil.

Shanghai Universal Biotech Co Research & Development Historical Data

The historical data trend for Shanghai Universal Biotech Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Universal Biotech Co Research & Development Chart

Shanghai Universal Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.73 16.77 34.37 58.61 62.77

Shanghai Universal Biotech Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.64 16.03 14.14 17.96 14.60

Shanghai Universal Biotech Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Universal Biotech Co  (SZSE:301166) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Shanghai Universal Biotech Co Research & Development Related Terms

Thank you for viewing the detailed overview of Shanghai Universal Biotech Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Universal Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Universal Biotech Co Ltd (SZSE:301166) » Definitions » Research & Development
Comparable Companies
BJSE:839729 BJSE:837344 SHSE:600200 SHSE:688137 SZSE:002566 SZSE:301258 SZSE:002868 SHSE:688098 SZSE:002873 SZSE:000518 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
No. 1690 Kongjiang Road, Room 1505, Yangpu District, Shanghai, CHN, 200082
Website
https://www.univ-bio.com
Shanghai Universal Biotech Co Ltd is a focused on antibodies and related products. It is a professional and comprehensive antibody suppliers and antibodies experts , and has a one-stop efforts to develop a life sciences service providers.
Executives
Leng Zhao Wen Director

Shanghai Universal Biotech Co Headlines

No Headlines